STEMPOINT CAPITAL LP

Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 6,030,028 shares
Security Ownership %: 8.4%

Shares, Excluding Options vs Price

Value, Excluding Options

StemPoint Capital LP ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

17 Feb 2026 - StemPoint Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,030,028 shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO). This represents 8.4% ownership of the company. In their previous filing dated 14 Nov 2025, STEMPOINT CAPITAL LP had reported owning 4,000,000 shares, indicating an increase of +51%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
StemPoint Capital LP	8.4%	+17%	$3,979,818	6,030,028	+2,030,028	+51%	$0.66	13G/A	31 Dec 2025	17 Feb 2026, 10:00
StemPoint Capital LP	7.2%		$3,371,600	4,000,000			$0.84	13G	30 Sep 2025	14 Nov 2025, 10:00

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.22%	+0.22%	$1,299,624	2,030,028	+2,030,028	NEW	$0.64	Q4 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.